X4 Pharmaceuticals Secures Up to $150 Million Senior Debt Facility with K2 HealthVentures
X4 Pharmaceuticals secured a senior secured term loan facility of up to $150 million with K2 HealthVentures, replacing its prior loan agreement. An $80 million first tranche funded at closing and fully repaid $75 million of principal under the prior facility; an additional $70 million is available at X4's request, subject to K2HV approval. The new facility carries a 48-month maturity and a longer interest-only period.
Key figures
- Deal Value Usd
- 150000000
- Maturity months
- 48
- Prior debt repaid
- $75 million principal
- Additional tranche
- $70 million
- First tranche funded
- $80 million
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.